The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) in the seizure-induced P-glycoprotein (P-gp) overexpression and the underlying mechanism. Kainic acid (KA)-induced mouse seizure model was used for in vivo experiments. Male C57BL/6 mice were divided into four groups: normal saline control (NS) group, KA-induced epileptic seizure (EP) group, and EP group pretreated with HMGB1 (EP+HMGB1 group) or BoxA (HMGB1 antagonist, EP+BoxA group). Compared to the NS group, increased levels of HMGB1 and P-gp in the brain were observed in the EP group. Injection of HMGB1 before the induction of KA further increased the expression of P-gp while pre-treatment with BoxA abolished this up-regulation. Next, the ...
Approximately 30% of epilepsy patients do not respond to antiepileptic drugs, representing an unmet ...
Background and Purpose—HMGB1 is a nuclear protein and an alarmin that signals cell damage in respons...
Epilepsy is a chronic brain disease afflicting around 70 million global population and is characteri...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Abstract Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable ne...
<p>(A) Immunohistochemical staining of P-gp in CA1 hippocampal areas of each group mice (NS group, <...
Toll-like receptor 4 (TLR4) activation in neuron and astrocytes by High Mobility Group Box 1 (HMGB1)...
Brain inflammation is a major factor in epilepsy, but the impact of specific inflammatory mediators ...
Approximately 30% of epilepsy patients experience seizures that are not controlled by the available ...
Background/Aims: Neuroinflammatory processes have been implicated in the pathophysiology of seizure/...
Epilepsy is a serious neurological condition exhibiting complex pathology and deserving of more seri...
High mobility group box-1 (HMGB1) is a non-histone, DNA-binding nuclear protein belonging to the fam...
Approximately 30% of epilepsy patients do not respond to antiepileptic drugs, representing an unmet ...
Background and Purpose—HMGB1 is a nuclear protein and an alarmin that signals cell damage in respons...
Epilepsy is a chronic brain disease afflicting around 70 million global population and is characteri...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Abstract Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable ne...
<p>(A) Immunohistochemical staining of P-gp in CA1 hippocampal areas of each group mice (NS group, <...
Toll-like receptor 4 (TLR4) activation in neuron and astrocytes by High Mobility Group Box 1 (HMGB1)...
Brain inflammation is a major factor in epilepsy, but the impact of specific inflammatory mediators ...
Approximately 30% of epilepsy patients experience seizures that are not controlled by the available ...
Background/Aims: Neuroinflammatory processes have been implicated in the pathophysiology of seizure/...
Epilepsy is a serious neurological condition exhibiting complex pathology and deserving of more seri...
High mobility group box-1 (HMGB1) is a non-histone, DNA-binding nuclear protein belonging to the fam...
Approximately 30% of epilepsy patients do not respond to antiepileptic drugs, representing an unmet ...
Background and Purpose—HMGB1 is a nuclear protein and an alarmin that signals cell damage in respons...
Epilepsy is a chronic brain disease afflicting around 70 million global population and is characteri...